Heterocyclic compounds and uses thereof
US10329299B2 · kind B2 · utility
4Cited by
248References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2017 |
| Grant date | Jun 25, 2019 |
| Priority date | — |
| Expiry date | Oct 26, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are compounds of Formula (I″) or (A″), pharmaceutical compositions comprising the compounds, and methods of use thereof. The compounds provided herein modulate kinase activity, including PI3 kinase activity, and are useful for treating diseases and conditions associated with kinase activity, including PI3 kinase activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.